Surgical Treatment of Inflammatory Bowel Diseases in the Elderly

  • Francesco Colombo
  • Gianluca Pellino
  • Gianluca Sampietro
  • Francesco Selvaggi
  • Silvestro Canonico
  • Diego FoschiEmail author


The prevalence of inflammatory bowel diseases (IBD) in the elderly population is increasing, reflecting ageing in the general population and late-onset of ulcerative colitis (UC) and Crohn’s disease (CD). Both CD and UC in elderly patients show specific clinical characteristics, changing the algorithm of the medical and surgical treatment. Immunomodulators and biologics are rarely used in patients over 65 years due to the risk of septic complications. Surgery involves less invasive and simpler procedures, favouring safety over functional results. The revision of our series and a careful analysis of the literature do not support this clinical approach, because the short-term results of surgery are the same in young and elderly IBD patients.


  1. 1.
    Hawkins C. Historical review. In: Allan RN, Keighley MRB, Alexander-Williams J, Hawkins C, editors. Inflammatory bowel diseases. Edinburgh: Churchill Livingstone Pub; 1983. p. 1–7.Google Scholar
  2. 2.
    Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.PubMedCrossRefGoogle Scholar
  3. 3.
    Tragnone A, Corrao G, Miglio F, et al. Incidence of inflammatory bowel disease in Italy: a nation-wide population-based study. Gruppo italiano per lo studio del colon e del retto (GISC). Int J Epidemiol. 1996;25:1044–52.PubMedCrossRefGoogle Scholar
  4. 4.
    Lakatos P, David G, Pandur T. IBD in the elderly population: results from a population based study in western Hungary. 1997–2008. J Crohns Colitis. 2011;5:5–13.PubMedCrossRefGoogle Scholar
  5. 5.
    Shivananda S, Lennard Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996;39:690–7.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Stepaniuk P, Bernstein CN, Targownik LE, Singh H. Characterization of inflammatory bowel disease in elderly patients: a review of epidemiology, current practices and outcomes of current management strategies. Can J Gastroenterol Hepatol. 2015;29:327–33.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Jeuring SFG, Van den Henvel TRA, Zeegers MP. Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age- an increasing distinct entity. Inflamm Bowel Dis. 2016;22:1425–34.PubMedCrossRefGoogle Scholar
  8. 8.
    Loftus CG, Loftus EV, Scott Harmsen W, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Holmsted County. Minnesota 1940–2000. Infl Bowel Dis. 2007;13:254–61.CrossRefGoogle Scholar
  9. 9.
    Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflammm Bowel Dis. 2009;15:182–9.CrossRefGoogle Scholar
  10. 10.
    Fries W, Viola A, Manetti N, et al. Disease patterns in late-onset ulcerative colitis: results from the IG-IBD “AGED study”. Dig Liver Dis. 2017;49:17–23.PubMedCrossRefGoogle Scholar
  11. 11.
    Del Val JH. Old age inflammatory bowel disease onset: a different problem? World J Gastroenterol. 2011;17:2734–9.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Taleban S, Colombel JF, Mohler MJ, Fain MJ. Inflammatory bowel disease and the elderly: a review. J Crohns Colitis. 2015;9:507–15.PubMedCrossRefGoogle Scholar
  13. 13.
    Charpentier C, Salleron J, Savoye G, et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut. 2014;63:423–32.PubMedCrossRefGoogle Scholar
  14. 14.
    DeRidder L, Weersma RK, Dijkstra G, et al. Genetic susceptibility has a more important role in pediatric-onset Crohn’s disease than in adult-onset Crohn’s disease. Inflamm Bowel Dis. 2007;13:1083–92.CrossRefGoogle Scholar
  15. 15.
    Bitton A, Vutcovici M, Paternande V, et al. Epidemiology of inflammatory bowel disease in Quebec: recent trends. Inflamm Bowel Dis. 2014;20:1770–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Gower-Rousseau C, Vasseur F, et al. Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis. 2013;45:89–94.PubMedCrossRefGoogle Scholar
  17. 17.
    Nguyen GC, Bernstein C, Benchimol EI. Risk of surgery and mortality in elderly-onset inflammatory bowel disease: a population-based cohort study. Inflamm Bowel Dis. 2017;23:218–23.PubMedCrossRefGoogle Scholar
  18. 18.
    Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol. 2011;106:1889–97.PubMedCrossRefGoogle Scholar
  19. 19.
    Freeman HJ. Age-dependent phenotypic clinical expression of Crohn’s disease. J Clin Gastroenterol. 2005;39:774–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Quezada SM, Steinberger EK. Association of age at diagnosis and Crohn’s disease phenotype. Age Ageing. 2013;42:102–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Juneja M, Baidoo L, Schwartz MB, et al. Geriatric inflammatory bowel disease: phenotipic presentation, treatment patterns, nutritional status, outcomes and comorbidity. Dig Dis Sci. 2012;57:1408–15.CrossRefGoogle Scholar
  22. 22.
    Brassard P, Bittou A, Suisse A, et al. Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel disease. Am J Gastroenterol. 2014;109:1795–802.PubMedCrossRefGoogle Scholar
  23. 23.
    Gisbert JP, Chaparro M. Systematic review with metanalysis: inflammatory bowel disease in the elderly. Alim Pharmacol Ther. 2014;39:459–77.CrossRefGoogle Scholar
  24. 24.
    Baars JE, Kuipers EJ, van Haastent M, et al. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease. A nation-wide, long-term survey. J Gastroenterol. 2012;47:1308–22.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Brackmann S, Andersen SN, Aamodt G, et al. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Scand J Gastroenterol. 2009;44:46–55.PubMedCrossRefGoogle Scholar
  26. 26.
    Sturm A, Maaser C, Mendall M, et al. European Crohn’s and colitis organisation topical review on IBD in the elderly. J Crohns Colitis. 2016;11(3):263–73.PubMedGoogle Scholar
  27. 27.
    Travis S. Is IBD different in the elderly? Inflamm Bowel Dis. 2008;14:S12–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Chaparro M, Ordas I, Cabre E, et al. Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm Bowel Dis. 2013;19:1404–10.PubMedCrossRefGoogle Scholar
  29. 29.
    Gisbert JP, Marin AC, Chaparro M. Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy. Alim Pharmacol Ther. 2015;42:391–405.CrossRefGoogle Scholar
  30. 30.
    Lichtenstein GR, Feagan BG, Cohen RD, et al. Drug therapies and the risk of malignancies: results from the TREAT registry. Am J Gastroenterol. 2010;105:501–23.CrossRefGoogle Scholar
  31. 31.
    Cottone M, Kohn A, Deperno M, et al. Advance age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:30–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Targownik LE, Singh H, Nugent Z, et al. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol. 2012;107:1228–35.PubMedCrossRefGoogle Scholar
  33. 33.
    Ananthakrishnan AN, Shi HY, Tang W, et al. Systematic review and meta-analysis: phenotype and clinical outcomes of older onset inflammatory bowel disease. J Crohns Colitis. 2016;10:1224–36.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Fumery M, de Chambrun GP, Stefanescu C, et al. Detection of dysplasia or cancer in 3.5% of patients with inflammatory bowel disease and colonic strictures. Clin Gastroenterol Hepatol. 2015;13:1770–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Ikeuchi H, Yamamura T, Nakano H, Kosaka T, Shimoyama T, Fukuda Y. Efficacy of nutritional therapy for perforating and non-perforating Crohn’s disease. Hepato-Gastroenterology. 2004;51:1050–2.PubMedGoogle Scholar
  36. 36.
    Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d’Hoore A, Pellino G, Dignass AU. European Crohn’s and colitis organisation topical review on prediction, diagnosis and Management of Fibrostenosing Crohn’s disease. J Crohns Colitis. 2016;10:873–85.PubMedCrossRefGoogle Scholar
  37. 37.
    Uchino M, Ikeuchi H, Bando T, Matsuoka H, Takahashi Y, Takesue Y, Matsumoto T, Tomita N. Risk factors for short bowel syndrome in patients with Crohn’s disease. Surg Today. 2012;42:447–52.PubMedCrossRefGoogle Scholar
  38. 38.
    Aytac E, Stocchi L, Remzi FH, Kiran RP. Is laparoscopic surgery for recurrent Crohn’s disease beneficial in patients with previous primary resection through midline laparotomy? A case-matched study. Surg Endosc. 2012;26:3552–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Pellino G, Selvaggi F, Ghezzi G, Corona D, Riegler G, Delaini GG. A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn’s disease. Tech Coloproctol. 2015;19:639–51.PubMedCrossRefGoogle Scholar
  40. 40.
    Selvaggi F, Pellino G, Canonico S, Sciaudone G. Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis. Inflamm Bowel Dis. 2015;21(1):79–92.PubMedCrossRefGoogle Scholar
  41. 41.
    Lovegrove RE, Tilney HS, Remzi FH, Nicholls RJ, Fazio VW, Tekkis PP. To divert or not to divert: a retrospective analysis of variables that influence ileostomy omission in ileal pouch surgery. Arch Surg. 2011;146:82–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Pellino G, Sciaudone G, Canonico S, Selvaggi F. Role of ileostomy in restorative proctocolectomy. World J Gastroenterol. 2012;18:1703–7.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Vavricka SR, Rogler G. Treatment of severe ulcerative colitis: differences in elderly patients? Dig Dis. 2009;27:315–21.PubMedCrossRefGoogle Scholar
  44. 44.
    Selvaggi F, Pellino G, Ghezzi G, Corona D, Riegler G, Delaini GG. A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis. Tech Coloproctol. 2015;19(10):627–38. Scholar
  45. 45.
    Selvaggi F, Pellino G, Canonico S, Sciaudone G. Systematic review of cuff and pouch cancer in patients with ileal pelvic pouch for ulcerative colitis. Inflamm Bowel Dis. 2014;20(7):1296–308.PubMedCrossRefGoogle Scholar
  46. 46.
    Øresland T, Bemelman WA, Sampietro GM, Spinelli A, Windsor A, Ferrante M, Marteau P, Zmora O, Kotze PG, Espin-Basany E, Tiret E, Sica G, Panis Y, Faerden AE, Biancone L, Angriman I, Serclova Z, de Buck van Overstraeten A, Gionchetti P, Stassen L, Warusavitarne J, Adamina M, Dignass A, Eliakim R, Magro F, D’Hoore A, European Crohn’s and Colitis Organisation (ECCO). European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis. 2015;9:4–25.PubMedGoogle Scholar
  47. 47.
    Annese V, Beaugerie L, Egan L, Biancone L, Bolling C, Brandts C, et al. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis. 2015;9(11):945–65.PubMedCrossRefGoogle Scholar
  48. 48.
    Derikx LA, Nissen LH, Oldenburg B, Hoentjen F. Controversies in pouch surveillance for patients with inflammatory bowel disease. J Crohns Colitis. 2016;10:747–51.PubMedCrossRefGoogle Scholar
  49. 49.
    Pellino G, Kontovounisios C, Tait D, Nicholls J, Tekkis PP. Squamous cell carcinoma of the anal transitional zone after Ileal pouch surgery for ulcerative colitis: systematic review and treatment perspectives. Case Rep Oncol. 2017;10:112–22.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Cohen JL, Strong SA, Hyman NH, et al. Standards practice task force American Society of Colon and Rectal Surgeons. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2005;48:1997–2009.PubMedCrossRefGoogle Scholar
  51. 51.
    Pellino G, Sciaudone G, Candilio G, Camerlingo A, Marcellinaro R, Rocco F, De Fatico S, Canonico S, Selvaggi F. Complications and functional outcomes of restorative proctocolectomy for ulcerative colitis in the elderly. BMC Surg. 2013;13(Suppl 2):S9.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Pellino G, Sciaudone G, Candilio G, De Fatico GS, Landino I, Canonico S, Selvaggi F. Restorative proctocolectomy with ileal pouch-anal anastomosis is safe and effective in selected very elderly patients suffering from ulcerative colitis. Int J Surg. 2014;12(Suppl 2):S56–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Delaney CP, Fazio VW, Remzi FH, et al. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal-pouch-anal anastomosis. Ann Surg. 2003;238:221–8.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Fazio VW, Tekkis PP, Remzi F, et al. Quantification of risk for pouch failure after ileal pouch anala anastomosis surgery. Ann Surg. 2003;238:605–14.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Colombo F, Sahami S, de Buck Van Overstraeten A, et al. Restorative proctocolectomy in elderly IBD patients: a multicentre comparative study on safety and efficacy. J Crohns Colitis. 2016;11(6):671–9.Google Scholar
  56. 56.
    Holubar SD, Privitera A, Cima RR, et al. Minimally invasive total proctocolectomy with Brooke ileostomy for ulcerative colitis. Inflamm Bowel Dis. 2009;15:1337–42.PubMedCrossRefGoogle Scholar
  57. 57.
    Stryker SJ, Pemebrton JH, Zinsmeister AR. Long-term results of ileostomy in older patients. Dis Colon Rectum. 1985;28:844–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Bauer JJ, Gorfine SR, Gelernt IM, et al. Restorative proctocolectomy in patients older than fifty years. Dis Colon Rectum. 1997;40:562–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Lewis WG, Sagar PM, Holdsworth PJ, et al. Restorative proctocolectomy with end to end pouch-anal anastomosis in patients over the age of fifty. Gut. 1993;34:948–52.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Ahmed Ali U, Keus F, Heikens JT, et al. Open vs laparoscopic (assisted) ileo-pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis. Cochrane Database Syst Rev. 2009;1:CD006267.Google Scholar
  61. 61.
    Buskens CJ, Sahami S, Tanis PJ, Bemelman WA. The potential benefits and disadvantages of laparoscopic surgery for ulcerative colitis: a review of current evidence. Best Pract Res Clin Gastroenterol. 2014;28:19–27.PubMedCrossRefGoogle Scholar
  62. 62.
    Argeny S, Stift A, Mittlbock M, et al. Advanced age impacts surgical characteristics and postoperative course in patients with Crohn’s disease. Int J Surg. 2016;33:182–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Bemelman WA, Allez M. The surgical intervention: earlier or never? Best Prac Res Clin Gastroenterol. 2014;28(3):497–503.CrossRefGoogle Scholar
  64. 64.
    Eshuis EJ, Polle SW, Slors JF, Hommes DW, Sprangers MA, Gouma DJ, et al. Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs. open ileocolic resection for Crohn’s disease: a comparative study. Dis Colon Rectum. 2008;51(6):858–67.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Eshuis EJ, Slors JF, Stokkers PC, Sprangers MA, Ubbink DT, Cuesta MA, et al. Long-term outcomes following laparoscopically assisted versus open ileocolic resection for Crohn’s disease. Br J Surg. 2010;97(4):563–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Lesperance K, Martin MJ, Lehmann R, Brounts L, Steele SR. National trends and outcomes for the surgical therapy of ileocolonic Crohn’s disease: a population-based analysis of laparoscopic vs. open approaches. J Gastrointest Surg. 2009;13(7):1251–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Maartense S, Dunker MS, Slors JF, Cuesta MA, Pierik EG, Gouma DJ, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn’s disease: a randomized trial. Ann Surg. 2006;243(2):143–9. discussion 50-3PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Milsom JW, Hammerhofer KA, Bohm B, Marcello P, Elson P, Fazio VW. Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn’s disease. Dis Colon Rectum. 2001;44(1):1–8. discussion -9PubMedCrossRefGoogle Scholar
  69. 69.
    Polle SW, Wind J, Ubbink DT, Hommes DW, Gouma DJ, Bemelman WA. Short-term outcomes after laparoscopic ileocolic resection for Crohn’s disease. A systematic review. Dig Surg. 2006;23(5–6):346–57.PubMedCrossRefGoogle Scholar
  70. 70.
    Schmidt CM, Talamini MA, Kaufman HS, Lilliemoe KD, Learn P, Bayless T. Laparoscopic surgery for Crohn’s disease: reasons for conversion. [erratum appears in Ann Surg 2001 Aug; 234(2):following table of contents]. Ann Surg. 2001;233(6):733–9.PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Stocchi L, Milsom JW, Fazio VW. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn’s disease: follow-up of a prospective randomized trial. Surgery. 2008;144(4):622–7. discussion 7-8PubMedCrossRefGoogle Scholar
  72. 72.
    Tilney HS, Constantinides VA, Heriot AG, Nicolaou M, Athanasiou T, Ziprin P, et al. Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a metaanalysis. Surg Endosc. 2006;20(7):1036–44.PubMedCrossRefGoogle Scholar
  73. 73.
    Gionchetti P, Dignass A, Danese S, On behalf of ECCO, et al. 3rd European. 3rd European evidence-based consensus on the diagnosis and Management of Crohn’s disease 2016: part 2: surgical management and special situations. J Crohns Colitis. 2016;11(2):1–16. Scholar
  74. 74.
    Maconi G, Carsana L, Fociani P, Sampietro GM, Ardizzone S, Cristaldi M, et al. Small bowel stenosis in Crohn’s disease: clinical, biochemical and ultrasonographic evaluation of histological features. Aliment Pharmacol Ther. 2003;18(7):749–56.PubMedCrossRefGoogle Scholar
  75. 75.
    Maconi G, Sampietro GM, Parente F, Pompili G, Russo A, Cristaldi M, et al. Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study. Am J Gastroenterol. 2003;98(7):1545–55.PubMedCrossRefGoogle Scholar
  76. 76.
    Maconi G, Sampietro GM, Sartani A, Bianchi Porro G. Bowel ultrasound in Crohn’s disease: surgical perspective. Int J Color Dis. 2008;23(4):339–47.CrossRefGoogle Scholar
  77. 77.
    Parente F, Greco S, Molteni M, Anderloni A, Sampietro GM, Danelli PG, et al. Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, x ray studies, and ileocolonoscopy. Gut. 2004;53(11):1652–7.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Parente F, Greco S, Molteni M, Cucino C, Maconi G, Sampietro GM, et al. Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel. Aliment Pharmacol Ther. 2003;18(10):1009–16.PubMedCrossRefGoogle Scholar
  79. 79.
    Parente F, Maconi G, Bollani S, Anderloni A, Sampietro G, Cristaldi M, et al. Bowel ultrasound in assessment of Crohn’s disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut. 2002;50(4):490–5.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Rimola J, Rodriguez S, Cabanas ML, Ayuso C, Panes J, Cuatrecasas M. MRI of Crohn’s disease: from imaging to pathology. Abdom Imaging. 2012;37(3):387–96.PubMedCrossRefGoogle Scholar
  81. 81.
    Clarke BW, Cassara JE, Morgan DR. Crohn’s disease of the esophagus with esophagobronchial fistula formation: a case report and review of the literature. Gastrointest Endosc. 2010;71(1):207–9.PubMedCrossRefGoogle Scholar
  82. 82.
    De Felice KM, Katzka DA, Raffals LE. Crohn’s disease of the Esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21(9):2106–13.PubMedCrossRefGoogle Scholar
  83. 83.
    Decker GA, Loftus EV Jr, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn’s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7(2):113–9.PubMedCrossRefGoogle Scholar
  84. 84.
    Fichera A, Michelassi F. Surgical treatment of Crohn’s disease. J Gastrointest Surg. 2007;11(6):791–803.PubMedCrossRefGoogle Scholar
  85. 85.
    Poggioli G, Stocchi L, Laureti S, Selleri S, Marra C, Salone MC, et al. Duodenal involvement of Crohn’s disease: three different clinicopathologic patterns. Dis Colon Rectum. 1997;40(2):179–83.PubMedCrossRefGoogle Scholar
  86. 86.
    Remes-Troche JM, Martinez-Benitez B, Valdovinos-Diaz MA. Crohn’s disease of the esophagus. Gastroenterology. 2006;130(4):1029. 376PubMedCrossRefGoogle Scholar
  87. 87.
    Rieder F, Hamer O, Gelbmann C, Scholmerich J, Gross V, Feuerbach S, et al. Crohn’s disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer “onyx”. Zeitschrift fur Gastroenterologie. 2006;44(7):599–602.PubMedCrossRefGoogle Scholar
  88. 88.
    Shapiro M, Greenstein AJ, Byrn J, Corona J, Greenstein AJ, Salky B, et al. Surgical management and outcomes of patients with duodenal Crohn’s disease. J Am Coll Surg. 2008;207(1):36–42.PubMedCrossRefGoogle Scholar
  89. 89.
    van Hogezand RA, Witte AM, Veenendaal RA, Wagtmans MJ, Lamers CB. Proximal Crohn’s disease: review of the clinicopathologic features and therapy. Inflamm Bowel Dis. 2001;7(4):328–37.PubMedCrossRefGoogle Scholar
  90. 90.
    Alexander-Williams J. The technique of intestinal strictureplasty. Int J Color Dis. 1986;1(1):54–7.CrossRefGoogle Scholar
  91. 91.
    Cristaldi M, Sampietro GM, Danelli PG, Bollani S, Bianchi Porro G, Taschieri AM. Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn’s disease using “bowel-sparing” techniques. Am J Surg. 2000;179(4):266–70.PubMedCrossRefGoogle Scholar
  92. 92.
    Di Abriola GF, De Angelis P, Dall’oglio L, Di Lorenzo M. Strictureplasty: an alternative approach in long segment bowel stenosis Crohn’s disease. J Pediatr Surg. 2003;38(5):814–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Fazio VW, Galandiuk S. Strictureplasty in diffuse Crohn’s jejunoileitis. Dis Colon Rectum. 1985;28(7):512–8.PubMedCrossRefGoogle Scholar
  94. 94.
    Hotokezaka M, Ikeda T, Uchiyama S, Hayakawa S, Tsuchiya K, Chijiiwa K. Side-to-side-to-end strictureplasty for Crohn’s disease. Dis Colon Rectum. 2009;52(11):1882–6.PubMedCrossRefGoogle Scholar
  95. 95.
    Lee EC, Papaioannou N. Minimal surgery for chronic obstruction in patients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl. 1982;64(4):229–33.PubMedPubMedCentralGoogle Scholar
  96. 96.
    Michelassi F, Taschieri A, Tonelli F, Sasaki I, Poggioli G, Fazio V, et al. An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn’s disease. Dis Colon Rectum. 2007;50(3):277–84.PubMedCrossRefGoogle Scholar
  97. 97.
    Sampietro GM, Cristaldi M, Maconi G, Parente F, Sartani A, Ardizzone S, et al. A prospective, longitudinal study of nonconventional strictureplasty in Crohn’s disease. J Am Coll Surg. 2004;199(1):8–20. discussion -2PubMedCrossRefGoogle Scholar
  98. 98.
    Sampietro GM, Cristaldi M, Porretta T, Montecamozzo G, Danelli P, Taschieri AM. Early perioperative results and surgical recurrence after strictureplasty and miniresection for complicated Crohn’s disease. Dig Surg. 2000;17(3):261–7.PubMedCrossRefGoogle Scholar
  99. 99.
    Tonelli F, Fazi M, Di Martino C. Ileocecal strictureplasty for Crohn’s disease: long-term results and comparison with ileocecal resection. World J Surg. 2010;34(12):2860–6.PubMedCrossRefGoogle Scholar
  100. 100.
    Fazio VW, Marchetti F, Church M, Goldblum JR, Lavery C, Hull TL, et al. Effect of resection margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled trial. Ann Surg. 1996;224(4):563–71. discussion 71-3PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Choy PY, Bissett IP, Docherty JG, Parry BR, Merrie A, Fitzgerald A. Stapled versus handsewn methods for ileocolic anastomoses. Cochrane Database Syst Rev. 2011;9:CD004320.Google Scholar
  102. 102.
    Simillis C, Jacovides M, Reese GE, Yamamoto T, Tekkis PP. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum. 2010;53(2):177–85.PubMedCrossRefGoogle Scholar
  103. 103.
    Andersson P, Olaison G, Hallbook O, Sjodahl R. Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum. 2002;45(1):47–53.PubMedCrossRefGoogle Scholar
  104. 104.
    de Oca J, Sanchez-Santos R, Rague JM, Biondo S, Pares D, Osorio A, et al. Long-term results of ileal pouch-anal anastomosis in Crohn’s disease. Inflamm Bowel Dis. 2003;9(3):171–5.PubMedCrossRefGoogle Scholar
  105. 105.
    Kiran RP, Nisar PJ, Church JM, Fazio VW. The role of primary surgical procedure in maintaining intestinal continuity for patients with Crohn’s colitis. Ann Surg. 2011;253(6):1130–5.PubMedCrossRefGoogle Scholar
  106. 106.
    Martel P, Betton PO, Gallot D, Malafosse M. Crohn’s colitis: experience with segmental resections; results in a series of 84 patients. J Am Coll Surg. 2002;194(4):448–53.PubMedCrossRefGoogle Scholar
  107. 107.
    Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn’s disease. Lancet. 1996;347(9005):854–7.PubMedCrossRefGoogle Scholar
  108. 108.
    Polle SW, Slors JF, Weverling GJ, Gouma DJ, Hommes DW, Bemelman WA. Recurrence after segmental resection for colonic Crohn’s disease. Br J Surg. 2005;92(9):1143–9.PubMedCrossRefGoogle Scholar
  109. 109.
    Prudhomme M, Dehni N, Dozois RR, Tiret E, Parc R. Causes and outcomes of pouch excision after restorative proctocolectomy. Br J Surg. 2006;93(1):82–6.PubMedCrossRefGoogle Scholar
  110. 110.
    Tekkis PP, Purkayastha S, Lanitis S, Athanasiou T, Heriot AG, Orchard TR, et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn’s disease: a meta-analysis. Color Dis. 2006;8(2):82–90.CrossRefGoogle Scholar
  111. 111.
    Cahill C, Gordon PH, Petrucci A, Boutros M. Small bowel adenocarcinoma and Crohn’s disease: any further ahead than 50 years ago? World J Gastroenterol. 2014;20(33):11486–95.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23(8):1097–104.PubMedCrossRefGoogle Scholar
  113. 113.
    Dossett LA, White LM, Welch DC, Herline AJ, Muldoon RL, Schwartz DA, et al. Small bowel adenocarcinoma complicating Crohn’s disease: case series and review of the literature. Am Surg. 2007;73(11):1181–7.PubMedGoogle Scholar
  114. 114.
    Widmar M, Greenstein AJ, Sachar DB, Harpaz N, Bauer JJ, Greenstein AJ. Small bowel adenocarcinoma in Crohn’s disease. J Gastrointest Surg. 2011;15(5):797–802.PubMedCrossRefGoogle Scholar
  115. 115.
    Connelly TM, Koltun WA. The surgical treatment of inflammatory bowel disease-associated dysplasia. Expert Rev Gastroenterol Hepatol. 2013;7(4):307–21. quiz 22PubMedCrossRefGoogle Scholar
  116. 116.
    Kavanagh DO, Carter MC, Keegan D, Doherty G, Smith MJ, Hyland JM, et al. Management of colorectal cancer in patients with inflammatory bowel disease. Tech Coloproctol. 2014;18(1):23–8.PubMedCrossRefGoogle Scholar
  117. 117.
    Kiran RP, Nisar PJ, Goldblum JR, Fazio VW, Remzi FH, Shen B, et al. Dysplasia associated with Crohn’s colitis: segmental colectomy or more extended resection? Ann Surg. 2012;256(2):221–6.PubMedCrossRefGoogle Scholar
  118. 118.
    Maser EA, Sachar DB, Kruse D, Harpaz N, Ullman T, Bauer JJ. High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn’s colitis. Inflamm Bowel Dis. 2013;19(9):1827–32.PubMedGoogle Scholar
  119. 119.
    Van Cutsem E, Nordlinger B, Cervantes A, Group EGW. Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol. 2010;21(Suppl 5):v93–7.PubMedCrossRefGoogle Scholar
  120. 120.
    Stallmach A, Hagen S, Gharbi A, et al. Medical and surgical therapy of inflammatory bowel disease in the elderly – prospects and complications. J Crohns Colitis. 2011;5:177–88.PubMedCrossRefGoogle Scholar
  121. 121.
    Rieder F, Latella G, Magro F, Yuksel ES, Higgins PD, Di Sabatino A, et al. European Crohn’s and Colitis Organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohns Colitis. 2016;10:873–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Francesco Colombo
    • 1
  • Gianluca Pellino
    • 2
  • Gianluca Sampietro
    • 1
  • Francesco Selvaggi
    • 2
  • Silvestro Canonico
    • 2
  • Diego Foschi
    • 1
    Email author
  1. 1.General Surgery, Department of Medical Sciences L. SaccoUniversity of MilanMilanItaly
  2. 2.Unit of General and Geriatric Surgery, I PoliclinicoUniversità degli Studi della Campania “Luigi Vanvitelli”NaplesItaly

Personalised recommendations